Growth Metrics

Forte Biosciences (FBRX) Other Working Capital Changes (2016 - 2020)

Forte Biosciences (FBRX) has disclosed Other Working Capital Changes for 5 consecutive years, with -$59000.0 as the latest value for Q4 2020.

  • Quarterly Other Working Capital Changes fell 278.79% to -$59000.0 in Q4 2020 from the year-ago period, while the trailing twelve-month figure was $263000.0 through Dec 2020, up 8866.67% year-over-year, with the annual reading at $2.6 million for FY2025, 87.47% up from the prior year.
  • Other Working Capital Changes for Q4 2020 was -$59000.0 at Forte Biosciences, down from $1.7 million in the prior quarter.
  • The five-year high for Other Working Capital Changes was $1.7 million in Q3 2020, with the low at -$1.7 million in Q2 2020.
  • Average Other Working Capital Changes over 5 years is $18500.0, with a median of -$15000.0 recorded in 2016.
  • Peak annual rise in Other Working Capital Changes hit 10768.75% in 2020, while the deepest fall reached 1944.44% in 2020.
  • Over 5 years, Other Working Capital Changes stood at $195000.0 in 2016, then tumbled by 156.92% to -$111000.0 in 2017, then crashed by 618.02% to -$797000.0 in 2018, then soared by 104.14% to $33000.0 in 2019, then tumbled by 278.79% to -$59000.0 in 2020.
  • According to Business Quant data, Other Working Capital Changes over the past three periods came in at -$59000.0, $1.7 million, and -$1.7 million for Q4 2020, Q3 2020, and Q2 2020 respectively.